COVID-19 Treatment Clinic

at CHA Everett Hospital

CHA offers COVID-19 treatments using antiviral medications. 

When used early, these therapies can help treat mild-to-moderate COVID-19 in high-risk patients.

CHA also continues to offer COVID-19 prophylaxis using Evusheld, a monoclonal antibody.

Evusheld is a valuable tool for immunosuppressed patients. It is still available and recommended by the MA Department of Public Health.

How to Get Connected to Care

There are several ways to access these treatments: 

  • Your CHA provider can place a referral for you
  • You can self-refer by calling 781-338-0280
  • A non-CHA provider can make a referral for you by completing our Google form or by downloading and faxing a referral form to 978-367-9946.
Online Referrals (Google form)

Download and fax: Evusheld (PDF)

Download and fax: Remdesivir (PDF)

Available Treatments

PAXLOVID and Molnupiravir are oral medications (by mouth) that may be given within 5 days of symptom onset.

Remdesivir (VEKLURY) is an intravenous (IV) antiviral medication which requires infusion on 3 consecutive days and must be started within 7 days of symptom onset.

Evusheld (a monoclonal antibody) is an intramuscular (IM) injection available to patients who are not currently infected with COVID and are immunocompromised. This can help prevent future severe COVID disease, regardless of vaccine status.

Bebtelovimab (a monoclonal antibody) is no longer available for use in the treatment of COVID. 

Please remember that medications are not a substitute for vaccination. 

Everyone is still encouraged to get a COVID-19 vaccine as soon as they can, whether it is a first, second or booster dose.

Conditions We Treat


Affiliated with:
Teaching hospital of: